Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.
about
Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in miceOncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsProgress and prospects: immune responses to viral vectorsTraceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivoAnalysis of adenoviral attachment to human platelets.Platelets and infection - an emerging role of platelets in viral infection.TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusProtein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.The role of platelets in the pathogenesis of viral hemorrhagic feversEquid herpesvirus type 1 activates platelets.Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivoMagnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.Current advances and future challenges in Adenoviral vector biology and targetingProgress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cellsStrategies to overcome host immunity to adenovirus vectors in vaccine development.Helper-Dependent Adenoviral Vectors.Innate immunity to adenovirus.Advances and future challenges in adenoviral vector pharmacology and targeting.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Human platelets express CAR with localization at the sites of intercellular interaction.Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver.Reactive Oxygen Species Generated by CD45-Cells Distinct from Leukocyte Population in Platelet Concentrates Is Correlated with the Expression and Release of Platelet Activation Markers during Storage.
P2860
Q21134565-36FC5694-F9D5-4BA9-9DDD-7E9A4929965BQ26776553-CC8ED138-CB26-495D-A729-DA43B26D99D5Q28264531-B1567DE4-00B1-4121-B48A-A213A5139930Q28539158-14FE8396-F361-4865-BAC1-C6B625F9F8FDQ33383309-118F680F-D6BF-4437-A37C-A2C033CC6A7DQ33419642-90007C14-F46C-4BEE-9861-9B49D5A82CBDQ33785096-ABC3DF71-926E-41D6-B5F5-F63B8B450992Q33987093-83EBAE34-649F-471D-B7FB-0717FD03F471Q34975214-F73667BD-97CF-4C84-8FB9-1E4F7C7CB540Q35006603-76D5C1DF-9347-4FA4-AC64-1AA6BB50433CQ35186543-2476C1E7-6F78-4E3F-8F7E-E381C3307590Q35532410-C5344749-2F18-4D24-81C2-2622B015633BQ35557004-AD5A7FB4-BD01-451B-8800-A16705A02AD0Q35952192-BB9E26EF-E85E-4DD0-BEE6-BFA5D259B65AQ36463004-871B5EA1-0246-4E93-891A-46C84F778708Q37089746-CD88E668-2B39-4224-93BD-1062DE5FDF3BQ37116929-161210E2-CE36-42B6-9BDD-C9E8148CAE7CQ37148646-1335D4FC-71DB-481B-999F-413985000132Q37503253-3BB12BE6-E0F7-4ADD-9436-BB8E0750BFF4Q37582126-87759ED6-CFDC-4104-8F86-27D3E2768165Q37718852-58D6825B-99F0-4653-8E8F-4EBAE4D79361Q37859842-2E1DC34E-C715-4F5D-9598-2E0EC1015D56Q37945218-D13EA934-5186-4E5A-A930-AEE54073AA78Q38614156-9EE17B21-F4F7-4BA8-A373-6769796D00BBQ38696384-64B4EAF9-69B5-4F65-AC7C-36AE7DDFF0E1Q41786777-5BB2D82F-8F7E-4C87-B96D-6D7256DF9F83Q54968569-79921C37-CE58-4EE5-9405-317E6655AD38
P2860
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@ast
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@en
type
label
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@ast
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@en
prefLabel
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@ast
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@en
P2093
P1433
P1476
Adenovirus-induced thrombocyto ...... ccelerated platelet clearance.
@en
P2093
Andrea Labelle
David Lillicrap
Hisham S Elbatarny
Ian Mazzetti
Maha Othman
P304
P356
10.1182/BLOOD-2006-06-032524
P407
P577
2007-04-01T00:00:00Z